Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024
Compare Balance Sheet Results of Aarey Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
28.45
35.69
-7.24
-20.29%
Share Warrants & Outstandings
Total Reserve
107.51
99.25
8.26
8.32%
Shareholder's Funds
138.48
134.94
3.54
2.62%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
1.99
19.21
-17.22
-89.64%
Secured Loans
1.99
9.72
-7.73
-79.53%
Unsecured Loans
0.00
9.48
-9.48
-100.00%
Deferred Tax Assets / Liabilities
0.92
4.25
-3.33
-78.35%
Other Long Term Liabilities
0.00
1.84
-1.84
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.56
-0.56
-100.00%
Total Non-Current Liabilities
2.91
25.85
-22.94
-88.74%
Current Liabilities
Trade Payables
102.54
13.83
88.71
641.43%
Other Current Liabilities
11.07
10.69
0.38
3.55%
Short Term Borrowings
32.87
18.72
14.15
75.59%
Short Term Provisions
2.73
1.54
1.19
77.27%
Total Current Liabilities
149.21
44.78
104.43
233.21%
Total Liabilities
290.59
205.58
85.01
41.35%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
39.10
188.63
-149.53
-79.27%
Less: Accumulated Depreciation
22.88
104.19
-81.31
-78.04%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
16.22
84.44
-68.22
-80.79%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.20
-0.20
-100.00%
Intangible assets under development
0.00
1.00
-1.00
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.12
32.40
-30.28
-93.46%
Long Term Loans & Advances
6.64
21.42
-14.78
-69.00%
Other Non Current Assets
0.01
0.00
0.01
0.00%
Total Non-Current Assets
24.98
139.46
-114.48
-82.09%
Current Assets Loans & Advances
Current Investments
0.00
0.02
-0.02
-100.00%
Inventories
45.48
12.47
33.01
264.72%
Sundry Debtors
133.46
40.45
93.01
229.94%
Cash and Bank
1.47
1.32
0.15
11.36%
Other Current Assets
0.78
1.83
-1.05
-57.38%
Short Term Loans and Advances
84.41
10.04
74.37
740.74%
Total Current Assets
265.61
66.12
199.49
301.71%
Net Current Assets (Including Current Investments)
116.40
21.33
95.07
445.71%
Total Current Assets Excluding Current Investments
265.61
66.10
199.51
301.83%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
290.59
205.58
85.01
41.35%
Contingent Liabilities
0.00
20.87
-20.87
-100.00%
Total Debt
34.86
37.93
-3.07
-8.09%
Book Value per share (adjusted)
46.90
37.81
9.09
24.04%
Annual - Borrowings
Borrowings 34.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 16.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Annual - Investments
Investments 2.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Annual - Current Assets
Current Assets 265.61 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024






